
News|Articles|December 3, 2025
Digital Expression Control with GPEx® Lightning: Enabling Complex Biologics in CHO Cells
Author(s)Catalent
This scientific poster showcases how GPEx® Lightning enables precise, digital control of gene expression for complex biologics. By leveraging targeted integration into ~200 Dock sites and a single optimized construct, developers can fine-tune gene ratios for co-expression of enzymes, cofactors, and multi-chain proteins. Learn how this approach streamlines screening, boosts titers, and shortens timelines—even for products with unknown stoichiometry.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Trending on Pharmaceutical Technology
1
FDA Approval of Cytokinetics’ Myqorzo Reflects Specialty Cardio Drug Trend
2
How the Wegovy Pill Approval Reshapes Solid Dosage Manufacturing Strategy
3
Innovation and Market Exclusivity in the EU
4
Orchestrating the Pharmaceutical Future: Living Decision Engines and AI Integration
5